Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 26.39% is 61% above its 5-year average of 16.42%, near the high end of its 5-year range (-6.51%–39.59%).
As of the fiscal period ended Tuesday, June 30, 2026. 32.12% above its 12-month average of 19.97%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 26.39%.
RETURN ON EQUITY (ROE)
26.39%
RETURN ON EQUITY (ROE) AVG TTM
19.97%
RETURN ON EQUITY (ROE) AVG 3Y
25.44%
RETURN ON EQUITY (ROE) AVG 5Y
16.42%
RETURN ON EQUITY (ROE) AVG 10Y
8.86%
RETURN ON EQUITY (ROE) AVG 15Y
-20.70%
RETURN ON EQUITY (ROE) AVG 20Y
-34.89%
CURRENT VS TTM AVG
+32.12%
CURRENT VS 3Y AVG
+3.73%
CURRENT VS 5Y AVG
+60.76%
CURRENT VS 10Y AVG
+197.93%
CURRENT VS 15Y AVG
+227.51%
CURRENT VS 20Y AVG
+175.63%
SECTOR MEDIAN · HEALTHCARE
13.01%
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
+102.83%
vs the sector median at left
Insulet Corp.
Market Cap
$9.40B
Return on Equity (ROE)
26.39%
TTM Avg
19.97%
3Y Avg
25.44%
5Y Avg
16.42%
Market Cap
$9.74B
Return on Equity (ROE)
12.77%
TTM Avg
11.88%
3Y Avg
12.69%
5Y Avg
13.50%
Market Cap
$10.02B
Return on Equity (ROE)
11.23%
TTM Avg
7.12%
3Y Avg
6.90%
5Y Avg
7.16%
Market Cap
$10.09B
Return on Equity (ROE)
-0.17%
TTM Avg
18.91%
3Y Avg
22.60%
5Y Avg
24.60%
Market Cap
$10.10B
Return on Equity (ROE)
15.51%
TTM Avg
15.81%
3Y Avg
15.92%
5Y Avg
17.27%
Market Cap
$10.43B
Return on Equity (ROE)
9.77%
TTM Avg
10.54%
3Y Avg
10.84%
5Y Avg
19.93%
Market Cap
$10.43B
Return on Equity (ROE)
3.10%
TTM Avg
-8.94%
3Y Avg
-15.72%
5Y Avg
1.14%
Market Cap
$10.71B
Return on Equity (ROE)
20.31%
TTM Avg
18.80%
3Y Avg
15.17%
5Y Avg
15.31%
Market Cap
$10.80B
Return on Equity (ROE)
6.85%
TTM Avg
4.70%
3Y Avg
4.67%
5Y Avg
11.22%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Insulet Corp. (PODD) | $9.40B | 26.39% | 19.97% | 25.44% | 16.42% |
| Henry Schein, Inc. (HSIC)vs › | $9.74B | 12.77% | 11.88% | 12.69% | 13.50% |
| Globus Medical, Inc. (GMED)vs › | $10.02B | 11.23% | 7.12% | 6.90% | 7.16% |
| Molina Healthcare, Inc. (MOH)vs › | $10.09B | -0.17% | 18.91% | 22.60% | 24.60% |
| The Ensign Group, Inc. (ENSG)vs › | $10.10B | 15.51% | 15.81% | 15.92% | 17.27% |
| Align Technology, Inc. (ALGN)vs › | $10.43B | 9.77% | 10.54% | 10.84% | 19.93% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.43B | 3.10% | -8.94% | -15.72% | 1.14% |
| Universal Health Services, Inc. (UHS)vs › | $10.71B | 20.31% | 18.80% | 15.17% | 15.31% |
| The Cooper Companies, Inc. (COO)vs › | $10.80B | 6.85% | 4.70% | 4.67% | 11.22% |
| DaVita Inc. (DVA)vs › | $11.21B | N/A | 329.18% | 200.63% | 164.66% |
ROE
26.4%
ROA
11.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 26.39% |
| 2026-03-31 | 23.25% |
| 2025-12-31 | 16.31% |
| 2025-09-30 | 17.79% |
| 2025-06-30 | 16.14% |
| 2025-03-31 | 30.22% |
| 2024-12-31 | 34.52% |
| 2024-09-30 | 37.65% |
| 2024-06-30 | 39.59% |
| 2024-03-31 | 29.59% |
| 2023-12-31 | 28.16% |
| 2023-09-30 | 19.75% |
| 2023-06-30 | 11.36% |
| 2023-03-31 | 0.12% |
| 2022-12-31 | 0.97% |
| 2022-09-30 | 3.93% |
| 2022-06-30 | 8.19% |
| 2022-03-31 | 9.98% |
| 2021-12-31 | 3.13% |
| 2021-09-30 | -5.80% |
| 2021-06-30 | -6.51% |
| 2021-03-31 | 1.62% |
| 2020-12-31 | 1.13% |
| 2020-09-30 | 4.85% |
| 2020-06-30 | 3.21% |
| 2020-03-31 | 8.59% |
| 2019-12-31 | 15.24% |
| 2019-09-30 | 10.95% |
| 2019-06-30 | 6.95% |
| 2019-03-31 | 6.38% |
| 2018-12-31 | 1.55% |
| 2018-09-30 | -6.80% |
| 2018-06-30 | -9.68% |
| 2018-03-31 | -13.73% |
| 2017-12-31 | -16.93% |
| 2017-09-30 | -39.18% |
| 2017-06-30 | -46.26% |
| 2017-03-31 | -41.48% |
| 2016-12-31 | -45.73% |
| 2016-09-30 | -72.34% |
| 2016-06-30 | -229.31% |
| 2016-03-31 | -280.98% |
| 2015-12-31 | -215.91% |
| 2015-09-30 | -93.58% |
| 2015-06-30 | -61.93% |
| 2015-03-31 | -70.83% |
| 2014-12-31 | -61.43% |
| 2014-09-30 | -60.49% |
| 2014-06-30 | -75.81% |
| 2014-03-31 | -33.03% |
| 2013-12-31 | -36.10% |
| 2013-09-30 | -43.37% |
| 2013-06-30 | -31.66% |
| 2013-03-31 | -36.86% |
| 2012-12-31 | -117.41% |
| 2012-09-30 | -143.20% |
| 2012-06-30 | -119.70% |
| 2012-03-31 | -105.48% |
| 2011-12-31 | -80.07% |
| 2011-09-30 | -76.33% |
| 2011-06-30 | -66.13% |
| 2011-03-31 | -94.54% |
| 2010-12-31 | -91.38% |
| 2010-09-30 | -162.95% |
| 2010-06-30 | -152.85% |
| 2010-03-31 | -180.21% |
| 2009-12-31 | -150.48% |
| 2009-03-31 | -598.84% |
| 2008-09-30 | -253.34% |
| 2008-06-30 | -142.45% |
| 2008-03-31 | -83.99% |
| 2007-12-31 | -58.02% |
| 2007-09-30 | -50.63% |
| 2007-06-30 | -39.69% |
